Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BNTX
BNTX logo

BNTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BNTX News

BioNTech Q1 2026 Earnings Call Insights

5d agoseekingalpha

BioNTech to Lay Off 1,860 Employees, Shift Focus to Oncology

5d agoseekingalpha

BioNTech Reports Wider Q1 Net Loss Amid Revenue Decline

6d agoNASDAQ.COM

BioNTech Reaffirms 2026 Financial Guidance Amid Q1 Loss

6d agoseekingalpha

BioNTech Scheduled to Announce Q1 Earnings on May 5

6d agoseekingalpha

Netflix Authorizes $25 Billion Buyback Program to Boost Shareholder Confidence

Apr 23 2026Fool

Analysis of Investment Prospects in Healthcare Stocks

Apr 15 2026Fool

BioNTech Reports Phase 2 Results for HER2 Cancer Drug

Apr 13 2026NASDAQ.COM

BNTX Events

05/07 08:00
BioNTech Authorizes $1B Share Repurchase Program
BioNTech announced that it has authorized a new share repurchase program under which the company may repurchase American Depositary Shares, each representing one ordinary share of the company, for an aggregate amount of up to $1B. Repurchases under the Program may be made until and including May 6, 2027.
05/05 16:40
Major U.S. Averages Close Broadly Higher, Nasdaq Up 1.03%
The major averages closed broadly higher as oil pulled back, though the ceasefire between the U.S. and Iran continues to be fragile. However, U.S. Defense Secretary Pete Hegseth said the ceasefire "certainly holds" and claimed that two U.S. commercial ships have already "safely transited the strait, showing the lane is clear."Meanwhile, earnings remain strong and AI capital expenditures continue to act as a structural tailwind. There is persistent capital flow into semis and hyperscalers, with expectations for massive multi-year spend cycles anchoring estimates higher.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Palantirprovided areport for Q1PayPalreportedand provided its outlook for Q2 and FY26Coinbaseannounced plans to, or 700 employeesPfizerreportedand reiterated its FY26 guidancePinterestreportedand provided Q2 revenue guidance2. WALL STREET CALLS:Ulta Beautyto Buy at BofA on improved earnings flywheelRobloxto Neutral at Piper Sandler on lack of visibilityArgusChipotleto Buy, expects comp growth to accelerateStephensRepay Holdings, sees "two binary outcomes"Tractor Supplyto Neutral at Piper Sandler3. AROUND THE WEB:FDA officials have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, NY Times reportsHondaplans to shelve its $11B Canada EV plant as demand sputters, Nikkei reportsNissanis planning to cut roughly 10% of its European workforce and consolidate production lines at its Sunderland Plant as part of a broader restructuring effort, while exploring partnerships such as with Chery to utilize excess capacity and improve financial performance, FT saysBerkshirehas selected Gen Re chairman Charlie Shamieh to succeed Ajit Jain, Vice Chairman of Insurance Operations, when Jain decides to retire, Bloomberg reportsAppleis planning to release a new "Create a Pass' feature for its next iPhone software update, which will allow users to build and customize their digital tickets and gift cards in the Wallet app, Bloomberg says4. MOVERS:Backblazehigher afterand raising its guidance for FY26EverQuote, Digital Oceanand BRC Inc.increase afterDigi Power Xgains after signing aGeneDxlower afterand lowered its guidance for FY26BellRing Brandsand Adtranfalls after5. EARNINGS/GUIDANCE:Portillo's, with EPS and revenue missing consensusIPG Photonicsand provided guidance for Q2, with CEO Mark Gitin commenting, "I am pleased to share that first-quarter revenue came in above our expectations"Neuroneticsand backed its guidance for FY26Surgery Partnersand backed its guidance for FY26, with CEO Eric Evans commenting, "We are encouraged by our solid start to 2026"Expeditors, with EPS and revenue beating consensusINDEXES:The Dow rose 356.35, or 0.73%, to 49,298.25, the Nasdaq gained 258.33, or 1.03%, to 25,326.13, and the S&P 500 advanced 58.47, or 0.81%, to 7,259.22.
05/05 14:50
FDA Blocks Publication of Vaccine Safety Studies
Officials at the Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, according to The New York Times' Christina Jewett, who reports this was confirmed by a spokesman for the Department of Health and Human Services. Publicly traded companies that make vaccines and drugs include Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY), and Sanofi (SNY).

BNTX Monitor News

BioNTech's promising pipeline boosts stock to 20-day high

Apr 21 2026

BioNTech stock declines despite positive mRNA vaccine recommendations

Mar 18 2026

BioNTech to Launch Independent mRNA Company by 2026

Mar 10 2026

CDC Meeting Raises Concerns Over Vaccine Safety

Mar 03 2026

Goldman Sachs Upgrades BioNTech to Buy, Raises Price Target

Jan 22 2026

Goldman Sachs Upgrades BioNTech to Buy, Raises Price Target

Jan 21 2026

BioNTech to Advance Oncology Strategy with Strong Financial Backing

Jan 13 2026

Biontech SE rises on market strength and reaches 20-day high

Jan 07 2026

BNTX Earnings Analysis

BioNTech SE Earnings Report: Strategic Growth in 2025- Intellectia AI™
6 months ago
BioNTech Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch